New pages
From IDWiki
- 20:14, 2 January 2025 Meropenem-clavulanate (hist | edit) [298 bytes] Aidan (talk | contribs) (Created page with "==Background== *Combination occasionally used in the treatment of drug-resistant tuberculosis ==Dosing== *Meropenem 1 g IV every 8 hours plus amoxicillin-clavulanate 500 mg/125 mg p.o. three times daily (given orally at the start of every infusion of meropenem)")
- 22:43, 1 January 2025 Antimicrobial desensitization (hist | edit) [3,375 bytes] Aidan (talk | contribs) (Created page with "==Background== *Goal of creating temporary tolerance to an antimicrobial to which the patient has a history of hypersensitivity reaction *Must carefully evaluate risks and benefits")
- 14:54, 31 December 2024 CR:DOI:153e71f3813c5bd7c1b98f3c2c7e1076 (hist | edit) [494 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=humphries2023re |type=journal-article |title=Review of Clinical and Laboratory Diagnostics for Coccidioidomycosis |author=Ian H. McHardy;Bridget Barker;George R. Thompson|+sep=; |editor=Romney M. Humphries |journal=Journal of Clinical Microbiology |publisher=American Society for Microbiology |year=2023 |volume=61 |issue=5 |doi=10.1128/jcm.01581-22 |issn=0095-1137;1098-660X|+sep=; |retrieved-from=https://dx.doi.org/ |retrieved-on=2024-12...")
- 21:53, 25 December 2024 CR:DOI:5489fb50cc5cc7d3646573606d6b0255 (hist | edit) [635 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=wudel2024ca |type=journal-article |title=Canadian Public Health Laboratory Network (CPHLN) diagnostic recommendations for neurosyphilis in Canada |author=Bev Wudel;Rupeena Purewal;Todd F Hatchette;Derek Stein;Muhammad Morshed;Jessica Minion;Maud Vallée;Kristy Hayden;Camille Hamula|+sep=; |journal=Journal of the Association of Medical Microbiology and Infectious Disease Canada |publisher=University of Toronto Press Inc. (UTPress) |year=2024 |...")
- 21:48, 25 December 2024 CR:DOI:629349db9c2031fc71a2293537104ca8 (hist | edit) [575 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=kristensen2024ou |type=journal-article |title=Outcomes of Debridement, Antibiotics, and Implant Retention in the Management of Infected Total Knee Arthroplasty: Analysis of 5,178 Cases from the National Australian Registry |author=Nicolai K. Kristensen;Stuart A. Callary;Renjy Nelson;Dylan Harries;Michelle Lorimer;Paul Smith;David Campbell|+sep=; |journal=The Journal of Arthroplasty |publisher=Elsevier BV |year=2024 |doi=10.1016/j.arth.2024.12...")
- 19:20, 5 December 2024 Enterococcus hirae (hist | edit) [410 bytes] Aidan (talk | contribs) (Created page with "{{DISPLAYTITLE:''Enterococcus hirae''}} == Background == * Stain::Gram-positive Shape::coccus within the genus Genus::Enterococcus * Rare cause of infections in humans * Most frequent sources in one case series was biliary, followed by urine, followed by wound and peritonealCiteRef::piccinini2022 == Management == * Generally susceptible to ampicillin Category:Gram-positive cocci") Tag: Visual edit
- 18:52, 5 December 2024 CR:DOI:87678e2b05281665a571c6a6876ce03f (hist | edit) [496 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=piccinini2022Enterococcus hirae infections in the clinical practice |author=Daniele Piccinini;Enos Bernasconi;Caroline Di Benedetto;Gladys Martinetti Lucchini;Marco Bongiovanni|+sep=; |journal=Infectious Diseases |publisher=Informa UK Limited |year=2022 |volume=55 |issue=1 |pages=71-73 |doi=10.1080/23744235.2022.2125066 |issn=2374-4235;2374-4243|+sep=; |retrieved-from=https://dx.doi.org/ |retrieved-on=2024-12-05 |@show=true }}")
- 18:11, 5 December 2024 Roth spots (hist | edit) [637 bytes] Aidan (talk | contribs) (Created page with "== Background == * Finding on fundoscopy * Classically associated with infective endocarditis === Etiologies === * Subacute bacterial endocarditis * Leukemia * Myeloma * Anemia * Carbon monoxide poisoning * Prolonged intubation during anesthesia * Preeclampsia * Hypertension * Diabetic retinopathy * HIV retinopathy * Vitamin B12 deficiency * Complicated labour * Shaken baby syndrome * Intracranial hemorrhage from AVM or aneurysm * Acute...") Tag: Visual edit
- 14:52, 3 December 2024 Bacteroides thetaiotaomicron (hist | edit) [582 bytes] Aidan (talk | contribs) (Created page with "{{DISPLAYTITLE:''Bacteroides thetaiotaomicron''}} == Background == === Microbiology === * Anaerobic Stain::Gram-positive Shape::bacillus within the genus Genus::Bacteroides == Management == * Most reliably susceptible to metronidazole, followed by imipenem, then amoxicillin-clavulanic acid and piperacillin-tazobactamCiteRef::nagy2011an * Universally resistant to ampicillin, and not reliably susc...") Tag: Visual edit
- 14:51, 3 December 2024 CR:DOI:6b488e15ca0503c0ce6cc26c5fc17eba (hist | edit) [469 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=nagy2011an |type=journal-article |title=Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience |author=E. Nagy;E. Urbán;Carl Erik Nord|+sep=; |journal=Clinical Microbiology and Infection |publisher=Elsevier BV |year=2011 |volume=17 |issue=3 |pages=371-379 |doi=10.1111/j.1469-0691.2010.03256.x |issn=1198-743X |retrieved-from=https://dx.doi.org/ |retrieved-on=2024-12-03 |@show=true }}")
- 03:45, 16 November 2024 Endometriosis (hist | edit) [271 bytes] Aidan (talk | contribs) (Created page with "* Ectopic endometrial tissue * Symptoms include: abdominal pain with no relation to menstruation, pain during urination, pain during defecation, constipation or diarrhea, irregular bleeding, nausea or vomiting, and feeling tired or lacking energy Category:Gynecology") Tag: Visual edit
- 03:17, 16 November 2024 May-Thurner syndrome (hist | edit) [225 bytes] Aidan (talk | contribs) (Created page with "* Venous compression causing a syndrome of venous insufficiency, obstruction, or thrombosis * Most common cause is compression of left common iliac vein between the right common iliac artery and spine Category:Thrombosis") Tag: Visual edit
- 02:58, 14 November 2024 Aztreonam (hist | edit) [868 bytes] Aidan (talk | contribs) (Created page with "== Background == * The only drug in the monobactam class of monocyclic ß-lactam antibiotic * Originally isolated from Chromobacterium violaceum * Spectrum includes gram-negative aerobic bacteria ** Of special important, oftenn effective again ESBL-containing organisms, including metallo-ß-lactamases == Dosing == * UTI: 500 to 1000 mg IV every 8 to 12 hours * Moderately severe infections: 1 to 2 g IV every 8 to 12 hours * Severe or life-threatening infect...") Tag: Visual edit
- 02:48, 14 November 2024 Polymixins (hist | edit) [323 bytes] Aidan (talk | contribs) (Created page with "* Class of antibiotics * Includes polymixin B and colistin (polymixin E) * Spectrum includes gram-negative bacteria, including resistant gram-negatives ** Usually reserved for susceptible carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii")
- 02:26, 14 November 2024 Carbapenem-resistant Enterobacterales (hist | edit) [491 bytes] Aidan (talk | contribs) (Created page with "== Management == * First-line includes meropenem-vaborbactam or ceftazidime-avibactam, directed by susceptibility resultsCiteRef:paul2022eu * For metallo-β-lactamases or extensively resistant bacteria, consider cefiderocol * For non-severe infections, consider aminoglycosides, including plazomicin; tigecycline would be second-line, though it can be considered in pneumonia Category:Antimicrobial resistance") Tag: Visual edit
- 02:21, 14 November 2024 CR:DOI:dcffaa0c2ad4bfb1085d7e360eb6cc8d (hist | edit) [896 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=paul2022eu |type=journal-article |title=European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) |author=Mical Paul;Elena Carrara;Pilar Retamar;Thomas Tängdén;Roni Bitterman;Robert A. Bonomo;Jan de Waele;George L. Daikos;Murat Akova;Stephan Harbarth;Celine Pulcini;José Garnac...")
- 15:29, 11 November 2024 Mycoplasma pneumoniae (hist | edit) [2,188 bytes] Aidan (talk | contribs) (Created page with "{{DISPLAYTITLE:''Mycoplasma pneumoniae''}} == Background == * Atypical bacterium within the genus Genus::Mycoplasma * Incidence fluctuates with epidemic years every 3 to 7 years and non-epidemic years mostly very low rates * More common in late summer and fall during epidemic years == Clinical Manifestations == * Most commonly causes subacute pneumoniae within influenza-like illness followed by persistent cough and malaise * Hematologic manifestations include...") Tag: Visual edit
- 19:02, 5 November 2024 MATRix (hist | edit) [220 bytes] Aidan (talk | contribs) (Created page with "* Chemotherapeutic regimen that includes methotrexate, cytarabine, thiotepa, and rituximab * Indicated for primary CNS lymphoma Category:Oncology Category:Hematology Category:Chemotherapy") Tag: Visual edit
- 14:36, 1 November 2024 eGPA (hist | edit) [109 bytes] Aidan (talk | contribs) (Redirected page to Eosinophilic granulomatosis with polyantiitis) Tags: New redirect Visual edit
- 15:20, 30 October 2024 Desulfovibrio desulfuricans (hist | edit) [440 bytes] Aidan (talk | contribs) (Created page with "{{DISPLAYTITLE:''Desulfovibrio desulfuricans''}} == Background == * Cellular respiration:Anaerobic sulfate-reducing Stain::Gram-negative Shape::bacillus in the genus Genus::Desulfovibrio == Clinical Manifestations == * Usually associated with hepatobiliary or other gastrointestinal infections == Management == * Unclear, refer to Desulfovibrio Category:Anaerobes Category:Gram-negative bacilli") Tag: Visual edit
- 15:19, 30 October 2024 Desulfovibrio (hist | edit) [1,126 bytes] Aidan (talk | contribs) (Created page with "{{DISPLAYTITLE:''Desulfovibrio''}} * Genus of Cellular respiratory::anaerobic sulfate-reducing Stain::Gram-negative bacilli * Ubiquitous environmental organisms, including soil, water, and sewage * Includes a number of species, of which 5 have been isolated from clinical specimens: ** Desulfovibrio desulfuricans, the most common pathogen in the genus ** Desulfovibrio fairfieldensis, possibly the most virulent ** Desulfovibrio vulgar...") Tag: Visual edit
- 17:26, 22 October 2024 Platelet transfusion (hist | edit) [954 bytes] Aidan (talk | contribs) (Created page with "== Indications == *In non-immune thrombocytopenia, it is reasonable to maintain platelets over 10 *For procedures with low risk of blood loss (e.g. appendectomy, cholecystectomy, vaginal delivery) **Platelets less than 20: transfuse 1 dose **Platelets 20 to 50: transfuse 1 dose if significant bleeding occurs *For procedures with high risk of blood loss, transfuse 1 dose for platelets less than 50 *For neurosurgery, ophthalmologic procedures, or significant head trauma wi...") Tag: Visual edit
- 15:08, 22 October 2024 Fungal keratitis (hist | edit) [901 bytes] Aidan (talk | contribs) (Created page with "== Background == * Infection of the cornea * See also eye:Fungal Keratitis * Typically caused by traumatic inoculation === Microbiology === * Candida species including Candida albicans, Candida glabrata, Candida tropicalis, Candida krusei, and Candida parapsilosis Category:Ocular infections") Tag: Visual edit
- 13:57, 22 October 2024 Aspergillus udagawae (hist | edit) [1,372 bytes] Aidan (talk | contribs) (Created page with "{{DISPLAYTITLE:''Aspergillus udagawae''}} == Background == * Species of mold within the genus Genus::Aspergillus == Clinical Manifestations == * Rare cases of infection in humans * Cases that I could find in Pubmed in October 2024: ** Fungal canaliculitis in an immunocompetent patient, managed with drainage aloneCiteRef::nishihara2023is ** Fungal endocarditis in a patient with ALL that was fatal despite voriconazoleCiteRef::seki2017fa ** Dissemina...") Tag: Visual edit
- 13:55, 22 October 2024 CR:DOI:e24e1be2e0022abbeb7bdd820821c6f7 (hist | edit) [600 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=posteraro2011un |type=journal-article |title=Uncommon Neosartorya udagawae Fungus as a Causative Agent of Severe Corneal Infection |author=Brunella Posteraro;Romano Mattei;Fausto Trivella;Andrea Maffei;Antonio Torre;Elena De Carolis;Patrizia Posteraro;Giovanni Fadda;Maurizio Sanguinetti|+sep=; |journal=Journal of Clinical Microbiology |publisher=American Society for Microbiology |year=2011 |volume=49 |issue=6 |pages=2357-2360 |doi=10.1128/...")
- 13:54, 22 October 2024 CR:DOI:040ca4f27ba6b86983650733d3b2c378 (hist | edit) [750 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=gyotoku2012a |type=journal-article |title=A case of bronchial aspergillosis caused byAspergillus udagawaeand its mycological features |author=Hiroshi Gyotoku;Koichi Izumikawa;Hideki Ikeda;Takahiro Takazono;Yoshitomo Morinaga;Shigeki Nakamura;Yoshifumi Imamura;Tomoya Nishino;Taiga Miyazaki;Hiroshi Kakeya;Yoshihiro Yamamoto;Katsunori Yanagihara;Akira Yasuoka;Takashi Yaguchi;Hideaki Ohno;Yoshitsugu Miyzaki;Katsuhiko Kamei;Tetsuro Kanda;Shigeru Kohn...")
- 13:52, 22 October 2024 CR:DOI:e70347a4a85f7097d5077644e566ca71 (hist | edit) [509 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=escribano2013is |type=journal-article |title=Is Azole Resistance in Aspergillus fumigatus a Problem in Spain? |author=Pilar Escribano;Teresa Peláez;Patricia Muñoz;Emilio Bouza;Jesús Guinea|+sep=; |journal=Antimicrobial Agents and Chemotherapy |publisher=American Society for Microbiology |year=2013 |volume=57 |issue=6 |pages=2815-2820 |doi=10.1128/aac.02487-12 |issn=0066-4804;1098-6596|+sep=; |retrieved-from=https://dx.doi.org/ |retri...")
- 13:49, 22 October 2024 CR:DOI:0e7a116ccf348f0ea977f427419ed0c1 (hist | edit) [626 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=vinh2009in |type=journal-article |title=Invasive Aspergillosis Due toNeosartorya udagawae |author=Donald C. Vinh;Yvonne R. Shea;Janyce A. Sugui;Edgardo R. Parrilla‐Castellar;Alexandra F. Freeman;J. William Campbell;Stefania Pittaluga;Pamela A. Jones;Adrian Zelazny;David Kleiner;Kyung J. Kwon‐Chung;Steven M. Holland|+sep=; |journal=Clinical Infectious Diseases |publisher=Oxford University Press (OUP) |year=2009 |volume=49 |issue=...")
- 13:48, 22 October 2024 CR:DOI:c57f384b4fb5fb6505e5aaee052255e6 (hist | edit) [610 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=葛目2021骨髄 |title=骨髄異形成症候群治療中に発症したAspergillus udagawaeによる播種性アスペルギルス症 |author=亜弓 葛目;淳一朗 湯田;雅広 阿部;卓哉 山口;真理 久野;寛彦 山内;洋貴 中村;啓人 永田;成基 池;永梅 郭;茂樹 中村;義継 宮崎;陽介 南|+sep=; |journal=臨床血液 |publisher=一般社団法人 日本血液学会 |year=2021 |volume=62 |pages=51-54 |doi=10.11406...")
- 13:46, 22 October 2024 CR:DOI:a1cc7b7263ba02549caf38a5afacad45 (hist | edit) [564 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=seki2017fa |type=journal-article |title=Fatal fungal endocarditis by Aspergillus udagawae : an emerging cause of invasive aspergillosis |author=Atsuko Seki;Atsushi Yoshida;Yoko Matsuda;Mitsuhiro Kawata;Takashi Nishimura;Jun Tanaka;Yoshiki Misawa;Yuta Nakano;Ryoko Asami;Koji Chida;Ken Kikuchi;Tomio Arai|+sep=; |journal=Cardiovascular Pathology |publisher=Elsevier BV |year=2017 |volume=28 |pages=14-17 |doi=10.1016/j.carpath.2017.02.002 |issn...")
- 13:45, 22 October 2024 CR:DOI:0a9475044f84e3196f4eb49635878fdf (hist | edit) [535 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=nishihara2023is |type=journal-article |title=Isolation of <i>Aspergillus udagawae</i> in Canaliculitis: A Case Report |author=Yuji Nishihara;Takahito Nakamura;Yuki Sakai;Yumiko Ban;Masato Tashiro;Koichi Izumikawa;Kei Kasahara|+sep=; |journal=Medical Mycology Journal |publisher=The Japanese Society for Medical Mycology |year=2023 |volume=64 |issue=4 |pages=99-102 |doi=10.3314/mmj.23-00004 |issn=2185-6486;2186-165X|+sep=; |retrieved-from=h...")
- 13:27, 22 October 2024 CR:DOI:105c5ac67b92f84c60065a20abf33855 (hist | edit) [612 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=rouzaud2019is |type=journal-article |title=Isavuconazole Diffusion in Infected Human Brain |author=Claire Rouzaud;Vincent Jullien;Anne Herbrecht;Bruno Palmier;Simona Lapusan;Marjolaine Morgand;Romain Guéry;Amélie Dureault;François Danion;Stéphanie Puget;Lauriane Goldwirt;Fanny Lanternier;Olivier Lortholary|+sep=; |journal=Antimicrobial Agents and Chemotherapy |publisher=American Society for Microbiology |year=2019 |volume=63 |issue=10 |...")
- 13:27, 22 October 2024 CR:DOI:43c5348f1013a317a358a3f7c24e6829 (hist | edit) [548 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=davis2021is |type=journal-article |title=Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring |author=Matthew R Davis;Sandy Chang;Pryce Gaynor;Erin K McCreary;Paul Allyn|+sep=; |journal=Medical Mycology |publisher=Oxford University Press (OUP) |year=2021 |volume=59 |issue=9 |pages=939-942 |doi=10.1093/mmy/myab035 |issn=1369-3786;1460-2709|+sep=; |ret...")
- 13:25, 22 October 2024 CR:DOI:52055fd2ec7599a11d7aa6409a67f5e7 (hist | edit) [749 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=bergmann2024ph |type=journal-article |title=Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions |author=Felix Bergmann;Michael Wölfl-Duchek;Anselm Jorda;Valentin Al Jalali;Amelie Leutzendorff;Maria Sanz-Codina;Daniela Gompelmann;Karin Trimmel;Maria Weber;Sabine Eberl;Wisse Van Os;Iris K Minichmayr;Birgit Reiter;Thomas Stimpfl;Marco Idzko;Markus Zeitlinger|+sep=; |jour...")
- 13:24, 22 October 2024 CR:DOI:6f8e66eb82d245ff8b10d0e5b39bd9f9 (hist | edit) [615 bytes] Aidan (talk | contribs) (Created page with "{{#scite: |reference=lee2019ti |type=journal-article |title=Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice with Underlying Chronic Granulomatous Disease |author=Annie Lee;Brendan Prideaux;Min Hee Lee;Matthew Zimmerman;Enriko Dolgov;David S. Perlin;Yanan Zhao|+sep=; |journal=Antimicrobial Agents and Chemotherapy |publisher=American Society for Microbiology |year=2019 |volume=63 |issue=6...")
- 16:00, 18 October 2024 Small intestinal bacterial overgrowth (hist | edit) [710 bytes] Aidan (talk | contribs) (Created page with "== Clinical Manifestations == * Bloating, abdominal pain, gas * Rarely, steatorrhea * Traditionally a complication of GI surgery (particularly bypass surgery), though some hypothesize can contribute to dyspepsia, IBS, and other chronic issues == Diagnosis == * Carbohydrate breath tests that check for hydrogen and methane gases which are produced by the bacterial fermentation of sugars like lactulose or glucose ** Need to avoid antibiotics 4 weeks prior to testing, lax...") Tag: Visual edit
- 14:28, 18 October 2024 SIBO (hist | edit) [51 bytes] Aidan (talk | contribs) (Created page with "#REDIRECT [Small intestinal bacterial overgrowth]")
- 15:57, 16 October 2024 Hypogammaglobulinemia (hist | edit) [713 bytes] Aidan (talk | contribs) (Created page with "== Etiologies == * Primary hypogammaglobulinemia ** Common variable immunodeficiency (CVID) ** IgG subclass deficiencies, including IgG1, IgG2 ** Hyper-IgM syndrome ** ADA deficiency ** Hypomorphic recombination-activating gene mutation ** Artemis defect * Secondary hypogammaglobulinemia ** Decreased production *** Medications, including B-cell depletion (rituximab, CAR-T, BiTE), corticosteroids, antiepileptic medications, and chemotherapy *** Malign...") Tag: Visual edit
- 15:53, 15 October 2024 Primaquine (hist | edit) [601 bytes] Aidan (talk | contribs) (Created page with "== Background == * Antimalarial medication * Indications include malaria and Pneumocystis == Dosing == * Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial * Pneumocystis jirovecii: 30 mg p.o. once daily in combination with clindamycin for 21 days === Renal Dosing === * No dose adjustments. == Safety == * For G6PD deficiency, should be avoided or dose-reduced Category:Antimicrobials Category:Antimal...") Tag: Visual edit
- 13:45, 11 October 2024 Wiskott-Aldrich syndrome (hist | edit) [235 bytes] Aidan (talk | contribs) (Created page with "* Primary immunodeficiency * X-linked recessive defect in the WAS gene located at xP 11.22-23 * Characterized by eczema, thrombocytopenia, immunodeficiency Category:Genetic syndromes Category:Immunodeficiencies") Tag: Visual edit
